Krystal Biotech Inc (KRYS)
199.30
+13.85
(+7.47%)
USD |
NASDAQ |
Nov 08, 16:00
199.30
0.00 (0.00%)
After-Hours: 16:13
Krystal Biotech Revenue (TTM): 241.52M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 241.52M |
Date | Value |
---|---|
June 30, 2024 | 166.23M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
166.23M
Minimum
Jun 2024
241.52M
Maximum
Sep 2024
203.88M
Average
203.88M
Median
Revenue (TTM) Benchmarks
Bioventus Inc | 555.06M |
ADMA Biologics Inc | 330.24M |
Axsome Therapeutics Inc | 291.49M |
Amicus Therapeutics Inc | 493.67M |
Sarepta Therapeutics Inc | 1.640B |